[1] MUSCOGIURI G,ALTIERI B,ANNWEILER C,et al.Vitamin D and chronic diseases:the current state of the art[J].Arch Toxicol,2016,91(1):97-107.
[2] BARRAGAN M,GOOD M,KOLLS J K.Regulation of dendritic cell function by vitamin D[J].Nutrients,2015,7:8127-8151.
[3] BAEKE F,GYSEMANS C,KORF H,et al.Vitamin D insufficiency:implications for the immune system[J].Pediatr Nephrol,2010,25(9):1597-1606.
[4] WAMBERG L,PEDERSEN S B,REJNMARK L,et al.Causes of vitamin D deficiency and effect of vitamin D supplementation on metabolic complications in obesity:a review[J].Curr Obes Rep,2015,4:429-440.
[5] LANDRIER J F,MARCOTORCHINO J,TOURNIAIRE F.Lipophilic micronutrients and adipose tissue biology[J].Nutrients,2012,4:1622-1649.
[6] ROSS A C,TAYLOR C L,YAKTINE A L,et al.The 2011 dietary reference intakes for calcium and vitamin D:what dietetics practitioners need to know[J].J Am Diet Assoc,2011,111(4):524-531.
[7] BELLIA A,GARCOVICH C,D'ADAMO M,et al.Serum 25-hydroxy vitamin D levels are inversely associated with systemic inflammation in severe obese subjects[J].Intern Emerg Med,2013,8(1):33-40.
[8] JACKSON J L,JUDD S E,PANWAR B,et al.Associations of 25-hydroxyvitamin D with markers of inflammation,insulin resistance and obesity in black and white community-dwelling adults[J].Journal of Clinical & Translational Endocrinology,2016,5:21-25.
[9] LANDRIER J F,KARKENI E,MARCOTORCHINO J,et al.Vitamin D modulates adipose tissue biology:possible consequences for obesity?[J].Proc Nutr Soc,2016,75:38-46.
[10] NEVE A,CORRADO A,CANTATORE F.Immunomodulatory effects of vitamin D in peripheral blood monocyte derived macrophages from patients with rheumatoid arthritis[J].Clin Exp Med,2014,14(3):275-283.
[11] SLOKA S,SILVA C,WANG J,et al.Predominance of Th2 polarization by Vitamin D through a STAT6 dependent mechanism[J].J Neuroinflammation,2011,8:56.
[12] vin HQUOCLUHQUỒCLU'O'NG K,NGUYN L T.The beneficial role of vitamin D in obesity:possible genetic and cell signaling mechanisms[J].Nutr J,2013,12:89.
[13] BOLLAND M J,GREY A B,AMES R W,et al.The effects of seasonal variation of 25-hydroxyvitamin D and fat mass on a diagnosis of vitamin D sufficiency[J].Am J Clin Nutr,2007,86:959-964.
[14] PITTAS A G,NELSON J,MITRI J,et al.Plasma 25-hydroxyvitamin D and progression to diabetes in patients at risk for diabetes:an ancillary analysis in the diabetes prevention program[J].Diabetes Care,2012,35(3):565-573.
[15] GALLAGHER J C,YALAMANCHILI V,SMITH L M.The effect of vitamin D supplementation on serum 25OHD in thin and obese women[J].J Steroid Biochem Mol Biol,2013,136:195-200.
[16] PEREIRA-SANTOS M,COSTA P R,ASSIS A M,et al.Obesity and vitamin D deficiency:a systematic review and meta-analysis[J].Obes Rev,2015,16:341-349.
[17] WRIGHT C S,WEINHEIMER-HAUS E M,FLEET J C,et al.The apparent relation between plasma 25-hydroxyvitamin D and insulin resistance is largely attributable to central adiposity in overweight and obese adults[J].J Nutr,2015,145:2683-2689.
[18] MAI X M,CHEN Y,CARLOS A,et al.Cross-sectional and prospective cohort study of serum 25-Hydroxyvitamin D level and obesity in adults[J].American Journal of Epidemiology,2012,175(10):1029-1036.
[19] DRINCIC A T,ARMAS L A,van DIEST E E,et al.Volumetric dilution,rather than sequestration best explains the low vitamin D status of obesity[J].Obesity,2012,20(7):1444-1448.
[20] WORTSMAN J,MATSUOKA L Y,CHEN T C,et al.Decreased bioavailability of vitamin D in obesity[J].Am J Clin Nutr,2000,72(3):690-693.
[21] 肖玉联,都萍,谭美珍,等.单纯性肥胖儿童血清维生素D水平检测及干预效果观察[J].广东医学院学报,2012,30(3):270-271.
[22] CRUJEIRAS A B,CARREIRA M C,CABIA B,et al.Leptin resistance in obesity:an epigenetic landscape[J].Life Sci,2015,140:57-63.
[23] ABBAS M A.Physiological functions of vitamin D in adipose tissue[J].J Steroid Biochem Mol Biol,2017,165(PtB):369-381.
[24] BARREA L,SAVASTANO S,di SOMMA C,et al.Low serum vitamin D-status,air pollution and obesity:a dangerous liaison[J].Rev Endocr Metab Disord,2017,18(2):207-214.
[25] TAO S,YUAN Q,MAO L,et al.Vitamin D deficiency causes insulin resistance by provoking oxidative stress in hepatocytes[J].Oncotarget,2017,8(40):67605-67613.
[26] 张珍,刘春燕.维生素D与胰岛素抵抗[J].医学研究生学报,2013,26(5):528-532.
[27] LI B,BAYLINK D J,DEB C,et al.25-Dihydroxyvitamin D3 suppresses TLR8 expression and TLR8-mediated inflammatory responses in monocytes in vitro and experimental autoimmune encephalomyelitis in vivo[J].PLoS One,2013,8(3):e58808.
[28] CHIU K C,CHU A,GO V L,et al.Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction[J].Am J Clin Nutr,2004,79:820-825.
[29] FIORENTINO T V,PRIOLETTA A,ZUO P,et al.Hyperglycemia-induced oxidative stress and its role in diabetes mellitus related cardiovascular diseases[J].Curr Pharm Des,2013,19:5695-5703.
[30] FOROUHI N,MENON R,SHARP S,et al.Effects of vitamin D2 or D3 supplementation on glycaemic control and cardiometabolic risk among people at risk of type 2 diabetes:results of a randomized double-blind placebo-controlled trial[J].Diabetes Obes Metab,2015,18:392-400.
[31] 朱志平.应用受试者工作曲线评价血清25-羟基维生素D3诊断妊娠期糖尿病的价值[J].东南大学学报(医学版),2015,34(6):1009-1011. |
